Market snapshot: Oct 11, 2026, 9:47 PM UTC. Prices may have changed since this snapshot.

GroupKALSHI

Event GroupKALSHIFinancials

Medtronic cardiovascular growth in Q2

Total Volume

$7.15K

Events

Markets

Trade on Kalshi

Medtronic cardiovascular growth in Q2

Vol

$7.15K

Events

Markets

Kalshi

Platform StatsQuick Platform Comparison

Polymarket

markets · $0.00

Kalshi

markets · $7.15K

Price Spread

0.0%avg

max 0.0%

Arbitrage

of 0 cross-platform

Volume DistributionTotal: $7.15K

100%

Kalshi leads

Price ChartMatched Markets Price Graph

9 markets tracked

Will Medtronic plc report Above 8% cardiovascular organic revenue growth in Q2 2027?

No data available

Single-Platform Markets(9)

Market	Platform	Price
Will Medtronic plc report Above 8% cardiovascular organic revenue growth in Q2 2027?	Kalshi	91%
Will Medtronic plc report Above 9% cardiovascular organic revenue growth in Q2 2027?	Kalshi	76%
Will Medtronic plc report Above 10% cardiovascular organic revenue growth in Q2 2027?	Kalshi	55%
Will Medtronic plc report Above 10.5% cardiovascular organic revenue growth in Q2 2027?	Kalshi	41%
Will Medtronic plc report Above 11% cardiovascular organic revenue growth in Q2 2027?	Kalshi	31%
Will Medtronic plc report Above 11.5% cardiovascular organic revenue growth in Q2 2027?	Kalshi	25%
Will Medtronic plc report Above 12% cardiovascular organic revenue growth in Q2 2027?	Kalshi	22%
Will Medtronic plc report Above 13% cardiovascular organic revenue growth in Q2 2027?	Kalshi	15%
Will Medtronic plc report Above 14% cardiovascular organic revenue growth in Q2 2027?	Kalshi	5%

AI Analysis

Trader mode: Actionable analysis for identifying opportunities and edge

91%

Top Probability

$7.15K

Volume

Markets

Platforms

About This Event

cardiovascular organic revenue growth in Q2 2027 If Medtronic plc reports Above X cardiovascular organic revenue growth in Q2 2027, then the market resolves to Yes. Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names are the property of their respective owners. This market will close and expire early if the event occurs.

AI-generated analysis based on market data. Not financial advice.

Custom AI Analysis Prompt

Tap to expand

Open in:ChatGPT Claude Gemini Grok DeepSeek

**Role:** Expert Prediction Market Analyst & Trader
**Objective:** Analyze the provided betting market data to deliver actionable insights, identify mispricings, and perform scenario analysis.
**Current Date:** Sunday, October 11, 2026
**Context:** Prediction markets (Polymarket/Kalshi) are binary option markets where price (1-99) equals implied probability (1%-99%).

---

## 1. Event Snapshot
**Event:** Medtronic cardiovascular growth in Q2
**Category:** Financials | **Status:** active
**Resolution Date:** N/A (Unknown)
**Time Pressure:** Unknown

**Description:** cardiovascular organic revenue growth in Q2 2027 

If Medtronic plc reports Above X cardiovascular organic revenue growth in Q2 2027, then the market resolves to Yes. Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names are the property of their respective owners. This market will close and expire early if the event occurs.

**Resolution Criteria (Sample):**
"If Medtronic plc reports Above 9% cardiovascular organic revenue growth in Q2 2027, then the market resolves to Yes. Secondary rules: Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names "

## 2. Market liquidity & Volume
* **Total Volume:** $7.2K
* **Total Liquidity:** $0
* **Activity Level:** Low Activity (Vol/Liq Ratio: 0.00)

## 3. Market Data (Prices & Odds)
### 1. Will Medtronic plc report Above 9% cardiovascular organic revenue growth in Q2 2027?
- **Kalshi** (End: Mar 31, 2027): Vol $1.1K
  DATA: [Yes: 75.5% (0.0%)] | [No: 24.5% (0.0%)]

### 2. Will Medtronic plc report Above 8% cardiovascular organic revenue growth in Q2 2027?
- **Kalshi** (End: Mar 31, 2027): Vol $252
  DATA: [Yes: 90.5% (0.0%)] | [No: 9.5% (0.0%)]

### 3. Will Medtronic plc report Above 14% cardiovascular organic revenue growth in Q2 2027?
- **Kalshi** (End: Mar 31, 2027): Vol $1.1K
  DATA: [Yes: 4.5% (0.0%)] | [No: 95.5% (0.0%)]

### 4. Will Medtronic plc report Above 13% cardiovascular organic revenue growth in Q2 2027?
- **Kalshi** (End: Mar 31, 2027): Vol $1.6K
  DATA: [Yes: 15.0% (0.0%)] | [No: 85.0% (0.0%)]

### 5. Will Medtronic plc report Above 12% cardiovascular organic revenue growth in Q2 2027?
- **Kalshi** (End: Mar 31, 2027): Vol $1.5K
  DATA: [Yes: 22.0% (0.0%)] | [No: 78.0% (0.0%)]

### 6. Will Medtronic plc report Above 11.5% cardiovascular organic revenue growth in Q2 2027?
- **Kalshi** (End: Mar 31, 2027): Vol $962
  DATA: [Yes: 25.0% (0.0%)] | [No: 75.0% (0.0%)]

### 7. Will Medtronic plc report Above 11% cardiovascular organic revenue growth in Q2 2027?
- **Kalshi** (End: Mar 31, 2027): Vol $605
  DATA: [Yes: 31.0% (0.0%)] | [No: 69.0% (0.0%)]

### 8. Will Medtronic plc report Above 10.5% cardiovascular organic revenue growth in Q2 2027?
- **Kalshi** (End: Mar 31, 2027): Vol $14
  DATA: [Yes: 41.0% (0.0%)] | [No: 59.0% (0.0%)]

### 9. Will Medtronic plc report Above 10% cardiovascular organic revenue growth in Q2 2027?
- **Kalshi** (End: Mar 31, 2027): Vol $0
  DATA: [Yes: 55.0% (0.0%)] | [No: 45.0% (0.0%)]

---

## Analysis Instructions
Please provide a structured analysis using the following template:

### 1. Executive Summary
*   **Verdict:** [Most Likely Outcome]
*   **Confidence:** [0-100]%
*   **Timeframe:** [Immediate / Short-term / Long-term]
*   **Actionable Trade:** [Buy YES / Buy NO / Stay Away] (Include entry price target if applicable)
*   **Rationale:** 2-sentence summary of the core thesis.

### 2. Scenario Analysis
*   **Bull Case (Why YES goes up):** List specific catalysts or data points.
*   **Bear Case (Why YES goes down):** List specifics.
*   **Invalidation Point:** What happens to prove your thesis wrong?

### 3. Market Mechanics & Risks
*   **Liquidity/Volume Analysis:** Is the market efficient? Is it easy to exit?
*   **Cross-Platform Arbitrage:** (If applicable) Is the spread tradeable after fees?
*   **Time Decay:** How does time passing affect this position?

### 4. Signal Scores (0-100)
*   **Momentum:** [Score] (Price trend & velocity)
*   **Conviction:** [Score] (Volume backing the move)
*   **Information Edge:** [Score] (Likelihood of non-public info affecting price)
*   **Risk/Reward:** [Score] (Potential upside vs downside)

**Constraints:**
- Be direct and objective.
- Use bullet points for readability.
- If data is conflicting or insufficient, explicitly state "Low Confidence".

Tap text to select all

Educational content is AI-generated and sourced from Wikipedia. It should not be considered financial advice.

KALSHIFinancials

Medtronic cardiovascular growth in Q2

Volume$7.15K

Markets9

9 of 9

Sort:

KALSHI

Will Medtronic plc report Above 8% cardiovascular organic revenue growth in Q2 2027?

KALSHI

KKalshi

Yes 90.5¢No 9.5¢

KALSHICompanies

Will Medtronic plc report Above 8% cardiovascular organic revenue growth in Q2 2027?

If Medtronic plc reports Above 8% cardiovascular organic revenue growth in Q2 2027, then the market resolves to Yes. Secondary rules: Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names

KALSHI

Will Medtronic plc report Above 9% cardiovascular organic revenue growth in Q2 2027?

KALSHI

KKalshi

Yes 75.5¢No 24.5¢

KALSHICompanies

Will Medtronic plc report Above 9% cardiovascular organic revenue growth in Q2 2027?

If Medtronic plc reports Above 9% cardiovascular organic revenue growth in Q2 2027, then the market resolves to Yes. Secondary rules: Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names

KALSHI

Will Medtronic plc report Above 10% cardiovascular organic revenue growth in Q2 2027?

KALSHI

KKalshi

Yes 55.0¢No 45.0¢

KALSHICompanies

Will Medtronic plc report Above 10% cardiovascular organic revenue growth in Q2 2027?

If Medtronic plc reports Above 10% cardiovascular organic revenue growth in Q2 2027, then the market resolves to Yes. Secondary rules: Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names

KALSHI

Will Medtronic plc report Above 10.5% cardiovascular organic revenue growth in Q2 2027?

KALSHI

KKalshi

Yes 41.0¢No 59.0¢

KALSHICompanies

Will Medtronic plc report Above 10.5% cardiovascular organic revenue growth in Q2 2027?

If Medtronic plc reports Above 10.5% cardiovascular organic revenue growth in Q2 2027, then the market resolves to Yes. Secondary rules: Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand nam

KALSHI

Will Medtronic plc report Above 11% cardiovascular organic revenue growth in Q2 2027?

KALSHI

KKalshi

Yes 31.0¢No 69.0¢

KALSHICompanies

Will Medtronic plc report Above 11% cardiovascular organic revenue growth in Q2 2027?

If Medtronic plc reports Above 11% cardiovascular organic revenue growth in Q2 2027, then the market resolves to Yes. Secondary rules: Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names

No related news found

Discussion

0 Comments

Market Insights

Average Yes Price

40¢

Kalshi

Arbitrage Opps

Cross-Platform

Embed Widget

Add this market to your website

Volume

Platforms

HTML

<iframe src="https://predictpedia.com/embed/0SvEe8" width="400" height="160" frameborder="0" style="border-radius: 8px; max-width: 100%;" title="Medtronic cardiovascular growth in Q2"></iframe>

Trade This Market

Trade on Kalshi

Medtronic cardiovascular growth in Q2

Medtronic cardiovascular growth in Q2

Platform StatsQuick Platform Comparison

Price ChartMatched Markets Price Graph

Will Medtronic plc report Above 8% cardiovascular organic revenue growth in Q2 2027?

AI Analysis

About This Event

Custom AI Analysis Prompt

Educational Context

Events (1)

Medtronic cardiovascular growth in Q2

Markets (9)

Will Medtronic plc report Above 8% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 8% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 9% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 9% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 10% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 10% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 10.5% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 10.5% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 11% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 11% cardiovascular organic revenue growth in Q2 2027?

Related News & Context

Discussion

Market Insights

Share

Embed Widget

Trade This Market

Platform StatsQuick Platform Comparison

Price ChartMatched Markets Price Graph

Will Medtronic plc report Above 8% cardiovascular organic revenue growth in Q2 2027?

Custom AI Analysis Prompt

Medtronic cardiovascular growth in Q2

Will Medtronic plc report Above 8% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 8% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 9% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 9% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 10% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 10% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 10.5% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 10.5% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 11% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 11% cardiovascular organic revenue growth in Q2 2027?

Related News & Context

Discussion

Share

Embed Widget